{"id":"W3166227213","doi":"10.1183/16000617.0023-2021","title":"Future concepts in bronchodilation for COPD: dual-<i>versus</i>monotherapy","year":2021,"lang":"en","type":"review","venue":"European Respiratory Review","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Manchester Biomedical Research Centre; Genentech; National Institutes of Health; Glenmark Pharmaceuticals; Mylan; Regeneron Pharmaceuticals; Sunovion; York University; AstraZeneca; Dartmouth College; Chiesi Farmaceutici; CSL Behring; Gilead Sciences; Sanofi; American Thoracic Society; Pfizer; Biogen; GlaxoSmithKline; National Institute for Health and Care Research; Insmed; Veracyte; Teva Pharmaceutical Industries","keywords":"Bronchodilation; Medicine; COPD; Dual (grammatical number); Bronchodilator Agents; Intensive care medicine; Internal medicine; Bronchodilator; Asthma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002196162,0.0008980903,0.002092971,0.001968154,0.0002804507,0.001413607,0.001331493,0.001778196,0.004765981],"category_scores_gemma":[0.001916834,0.0003215037,0.001838654,0.001559625,0.0007121293,0.002580148,0.0007900451,0.003121342,0.001196335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009202952,"about_ca_system_score_gemma":0.001859951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001199393,"about_ca_topic_score_gemma":0.003296255,"domain_scores_codex":[0.9992932,0.0002503297,0.0001180707,0.00008151435,0.0002111722,0.0000457043],"domain_scores_gemma":[0.998961,0.000725921,0.0001369765,0.00002026421,0.0001226028,0.00003318395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003104721,0.0001006611,0.0001657663,0.1493255,0.0006161549,0.000208327,0.0001637991,0.0003556416,0.001475096,0.00992595,0.02267609,0.8146766],"study_design_scores_gemma":[0.0001609261,0.0003435205,0.001470165,0.07108797,0.0009732919,0.001362074,0.0002176616,0.0001515619,0.0002896553,0.006030658,0.9178813,0.00003119397],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003684761,0.9992369,0.00003660552,0.0003088592,0.0001522646,0.000003284577,0.00000509131,0.000001409894,0.0002186185],"genre_scores_gemma":[0.0005674409,0.9984596,0.0001312688,0.0004832272,0.0001357301,0.000009930138,0.00001274148,8.67752e-7,0.000199313],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004765981,"threshold_uncertainty_score":0.01594383,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1073933882071104,"score_gpt":0.4211041921774757,"score_spread":0.3137108039703653,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}